semaglutide step 4 Novo Nordisk announced headline results from UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Wegovy® Pen Guide and Dosing

Semaglutide was not originally used for weight lossits potency was a noted side effect, and now its changing lives all over the world

Semaglutide enhances insulin secretion in response to elevated blood glucose, suppresses glucagon release, slows gastric emptying, andcrucially for weight managementreduces appetite by acting on centres in the brain that regulate hunger and satiety

GLP-1 RAs also have a series of beneficial multifactorial effects beyond glycaemic control that include reduction of body weight and improvement of cardiovascular (CV) outcomes [14]

Similarly, certain anticonvulsants, particularly phenytoin and phenobarbital, may alter B12 metabolism and could theoretically affect the therapeutic response to methylcobalamin supplementation